Top2a identifies and provides epigenetic rationale for novel combination therapeutic strategies for aggressive prostate cancer

ABSTRACT: We perform RNA-seq on matched orthotopic murine primary and metastatic prostate cancer samples to identify differential gene expressions RNA-seq was performed on orthotopic murine primary and metastatic tumor samples using Illumina Hi-Seq 2000 platform

ORGANISM(S): Mus musculus

SUBMITTER: Qiang Hu 

PROVIDER: E-GEOD-64771 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress